| RINTEZEX NOVARTIS AG
1420339 02 Dec 2008 | on 25 Jun 2014 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use of ophthalmology. | | | RINTEZEX NOVARTIS AG
1135327 25 Mar 2002 | on 25 Jun 2008 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely preparations for the treatment of dermatitis, skin pigmentation diseases and the repair of tissue and skin; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the use in ophthalmology. | | 
